Ad
related to: biotech companies in north carolina- Science & Technology
See Regeneron's New Technology
Turning Science into Medicine
- Antibodies at Work
End-to-End Research & Development
See Regeneron's Approved Medicines
- Genetic Research
Speeding Drug Discovery
Learn about the RGC
- About Regeneron
Industry-Leading Biotechnology
Reinventing Drug Discovery
- Science & Technology
Search results
Results from the WOW.Com Content Network
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir (Rapivab) was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.
Locus Biosciences is a clinical-stage pharmaceutical company, founded in 2015 and based in Research Triangle Park, North Carolina. [2] Locus develops phage therapies based on CRISPR–Cas3 gene editing technology, as opposed to the more commonly used CRISPR-Cas9, delivered by engineered bacteriophages. [5]
For the second time in eight days, the Eastern North Carolina county of Wilson is celebrating the promise of a new pharmaceutical facility. Last week, the manufacturer of the cold and flu medicine ...
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. [3] Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform. [4]
The facility serves as the company's co-headquarters and is used for commercial manufacturing of active pharmaceutical ingredients and finished dosage form products. United Therapeutics also owns a 380,000-square-foot combination manufacturing plant and office building in Research Triangle Park, North Carolina.
In March 2021, the company announced that it had selected Holly Springs, North Carolina, located near its existing operations in Morrisville, for a $2 billion investment to establish a new large-scale cell culture production site, which is expected to be operational in 2025 and create 725 new jobs by the end of 2028. The company plans to ...
Wake Forest Biotech Building. Innovation Quarter in Winston-Salem, North Carolina, formerly Wake Forest Innovation Quarter, is an innovation district focused on research, business, and education in biomedical science, information technology, digital media, clinical services, and advanced materials. [1]
Even before the pandemic, biotech companies were receiving positive feedback from investors. In 2019, US biotech companies raised $5.6 billion in capital through initial public offerings (IPOs ...
Ad
related to: biotech companies in north carolina